Antiviral host defense through selective translational inhibition
Antiviral host defense through selective translational inhibition
批准号:
8914843
负责人:
MICHAEL DAVID
金额:
$0.84万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2016-05-31
关键词:
AIDS/HIV problemATP phosphohydrolaseAffectAlternative SplicingAnti-Retroviral AgentsAntigensAntiviral AgentsAntiviral ResponseAreaAttenuatedBindingBiogenesisBiological ProcessCaenorhabditis elegansCellsChargeCodon NucleotidesCommunicable DiseasesDNADevelopmentDiagnosticDiseaseDominant-Negative MutationDrosophila genusERG geneEmployee StrikesEventFamilyGenerationsGenesGenetic TranscriptionGoalsHIVHIV InfectionsHomologous GeneHost DefenseHumanIRF3 geneImmune responseInfectionInfection preventionInfluenzaInterferon-alphaInterferon-betaInterferonsKineticsLengthLightLocationMediatingMessenger RNAMolecularMolecular Mechanisms of ActionMulti-Drug ResistanceMusN-terminalNucleic Acid BindingOrganismPathway interactionsPharmaceutical PreparationsPositioning AttributePoxviridaeProcessProductionProtein BindingProtein BiosynthesisProtein InhibitionProtein IsoformsProtein Synthesis InhibitionProteinsRNA HelicaseReportingRetroviridaeReverse TranscriptionRoleShapesSpecificityStagingSystemTestingTherapeuticTherapeutic InterventionTransfer RNATranslational RepressionViralViral ProteinsVirusYeastsbasemembermicrobialnovelpathogenpreferenceprognosticprospectiveprotein expressionprotein functiontoolviral RNA
中文摘要
描述(由申请人提供):艾滋病毒仍然是世界上最流行的传染病之一。我们发现了一种新的细胞因子,可以抑制感染细胞产生HIV,这为开发新型抗病毒药物提供了新的靶点,并可能具有诊断和预后价值。此外,基于抗病毒活性的分子基础,我们假设其他病毒如流感病毒也会受到huSlfn11的抑制。
英文摘要
DESCRIPTION (provided by applicant): HIV continues to be one of the most prevalent infectious diseases in this world. Our discovery of a novel cellular factor that inhibits the production of HIV by infected cells provides a new target for the development of a novel class of anti-viral drugs and may additionally carry diagnostic and prognostic value. Furthermore, based on the molecular basis of the antiviral activity we hypothesize that other viruses such as Influenza will also be subject to inhibition by huSlfn11.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational inhibition by Schlafen proteins during the DNA damage response
-
批准号:10080748
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2019
-
负责人:MICHAEL DAVID
-
依托单位:
The IRF-type I interferon system during gestation
-
批准号:9300592
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2017
-
负责人:MICHAEL DAVID
-
依托单位:
DNA structure modification by the Schlafen protein family
-
批准号:9238658
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2016
-
负责人:MICHAEL DAVID
-
依托单位:
Role of TLR3 pathway in HIV infection
-
批准号:9508694
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2016
-
负责人:MICHAEL DAVID
-
依托单位:
Role of TLR3 pathway in HIV infection
-
批准号:9204258
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2016
-
负责人:MICHAEL DAVID
-
依托单位:
The IRF - type I interferon system in T cell-mediated immune tolerance
-
批准号:8492601
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2013
-
负责人:MICHAEL DAVID
-
依托单位:
The IRF - type I interferon system in T cell-mediated immune tolerance
-
批准号:8607894
-
项目类别:
-
资助金额:$22.07万
-
财政年份:2013
-
负责人:MICHAEL DAVID
-
依托单位:
Antiviral host defense through selective translational inhibition
-
批准号:8473888
-
项目类别:
-
资助金额:$28.42万
-
财政年份:2012
-
负责人:MICHAEL DAVID
-
依托单位:
Antiviral host defense through selective translational inhibition
-
批准号:8660064
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2012
-
负责人:MICHAEL DAVID
-
依托单位:
Antiviral host defense through selective translational inhibition
-
批准号:8892204
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2012
-
负责人:MICHAEL DAVID
-
依托单位:
Antiviral host defense through selective translational inhibition
-
批准号:8329334
-
项目类别:
-
资助金额:$29.44万
-
财政年份:2012
-
负责人:MICHAEL DAVID
-
依托单位:
Slfn proteins in innate immunity
-
批准号:8069241
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2010
-
负责人:MICHAEL DAVID
-
依托单位:
Interferon actions and autoimmune disorders
-
批准号:8094148
-
项目类别:
-
资助金额:$25.85万
-
财政年份:2010
-
负责人:MICHAEL DAVID
-
依托单位:
Slfn proteins in innate immunity
-
批准号:7875464
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2010
-
负责人:MICHAEL DAVID
-
依托单位:
Interferon actions and autoimmune disorders
-
批准号:7350943
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2007
-
负责人:MICHAEL DAVID
-
依托单位:
Interferon actions and autoimmune disorders
-
批准号:7560370
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2007
-
负责人:MICHAEL DAVID
-
依托单位:
Interferon actions and autoimmune disorders
-
批准号:7761259
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2007
-
负责人:MICHAEL DAVID
-
依托单位:
Interferon actions and autoimmune disorders
-
批准号:7260577
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2007
-
负责人:MICHAEL DAVID
-
依托单位:
Interferon modulation of cellular microRNAs in the Hepatitis C antiviral defense
-
批准号:7298727
-
项目类别:
-
资助金额:$28.51万
-
财政年份:2007
-
负责人:MICHAEL DAVID
-
依托单位:
Interferon modulation of cellular microRNAs in the Hepatitis C antiviral defense
-
批准号:7880654
-
项目类别:
-
资助金额:$27.66万
-
财政年份:2007
-
负责人:MICHAEL DAVID
-
依托单位: